Beta-Arrestin Signalling
Beta-arrestin signalling is the arm of receptor activity in which arrestin proteins bind a phosphorylated receptor, uncouple it from G proteins, and drive its internalisation and further signalling.
When an agonist occupies a G protein-coupled receptor, G protein-coupled receptor kinases phosphorylate the receptor's intracellular tail. Beta-arrestin then binds that phosphorylated tail and physically blocks the G protein interface, which is the molecular event behind desensitisation. The same arrestin acts as an adaptor for clathrin-coated pits, pulling the receptor off the surface, and as a scaffold assembling kinase cascades such as ERK. So the pathway does three jobs at once: it stops one signal, redistributes the receptor, and starts a second signal.
Two non-visual isoforms, beta-arrestin-1 and -2, cover most receptors, with distinct visual arrestins in the retina. In screening, arrestin recruitment is read out by proximity assays such as bioluminescence resonance energy transfer or enzyme-fragment complementation, and reported as its own concentration-response curve alongside a cAMP curve. The therapeutic idea that G protein and arrestin arms can be separated produced oliceridine, an opioid agonist designed to avoid arrestin recruitment, which reached FDA approval in 2020.
Knowing the arrestin profile tells you how a receptor will behave under sustained exposure: strong recruitment predicts faster desensitisation, internalisation and trafficking, while weak recruitment predicts a receptor that stays on the surface and keeps signalling. That matters more for a weekly agonist than for an acute one.
The common misreading is arrestin as the toxicity pathway and G protein as the benefit. The genetic evidence that launched the biased-opioid programme, resting on arrestin-2 knockout mice, was not reproduced in later work, and the clean split did not survive contact with the data. Internalised receptors also continue to signal from endosomes, so arrestin recruitment is not simply switching off.